pictore
Curaleaf Holdings, Inc. (OTCPK:CURLF) uplisted to the Toronto Stock Exchange on December 14. The share structure to achieve this goal isn’t likely to attract major institutional investors, leaving the multi-state operator (“MSO”) trading at a ridiculously low valuation. My investment thesis remains Bullish on the cannabis stock, but Curaleaf needs regulatory action and positive cash flows, not stock exchange tricks.
TSX Uplisting
At the opening bell on December 14, Curaleaf officially uplisted to the TSX under the ticker symbol “CURA” from the Canadian Securities Exchange, or CSE. Most importantly, the stock won’t be uplisting to the major U.S. exchanges of the NYSE and Nasdaq.
Executive Chairman Boris Jordan made the following statement in connection with announcing the official uplisting:
As Curaleaf is now eligible for inclusion into indexes such as TSX and MSCI, this uplisting will ultimately provide significantly…
